| Literature DB >> 34294645 |
Marta Kramer Mikkelsen1, Hanne Michelsen, Dorte Lisbet Nielsen, Anders Vinther, Cecilia Margareta Lund, Mary Jarden.
Abstract
BACKGROUND: Sparse evidence exists regarding the feasibility and patients' experiences of exercise programs among older cancer populations.Entities:
Mesh:
Year: 2022 PMID: 34294645 PMCID: PMC8849132 DOI: 10.1097/NCC.0000000000000987
Source DB: PubMed Journal: Cancer Nurs ISSN: 0162-220X Impact factor: 2.592
Interview Guide
| Research Topics | Interview Questions |
|---|---|
| Initial motivation for participation | Tell me about your decision to participate in the program |
| Experiences from participation in the PACE-Mobil-PBL program | What has it been like to participate in the program? |
| Motivation to exercise during the program | What motivated you to exercise during your participation (team-based and home-based walking)? |
| Barriers | What (if anything) made it difficult to participate/perform in the exercise program? |
| Experienced gain from participation | What (if anything) have you gained from participating in the program? |
| Ideas for improvement | Do you have any suggestions on how to improve the program? |
| Closure | Would you recommend the program to other patients? |
Abbreviation: PACE-Mobil-PBL, Patient Activation Through Counseling, Exercise, and Mobilization in Older Patients With Advanced Pancreatic, Biliary tract and Lung Cancer.
Questions from the Written Evaluation Questionnaires
| Please tell us about your experiences from participation in the PACE-Mobil-PBL program. All experiences—good and bad—are appreciated and will help us to develop the most optimal exercise programs in the future. |
| What did you like about the program? |
| What did you not like about the program? |
| What could be improved in the program? |
| Additional comments: |
Abbreviation: PACE-Mobil-PBL, Patient Activation Through Counseling, Exercise, and Mobilization in Older Patients With Advanced Pancreatic, Biliary tract and Lung Cancer.
Medical and Demographic Characteristics of the Participants
| No./ID | Age | Sex | Treatment | ECOG PS | CCI | Living Status | Working Status | Adherence (%)a | |
|---|---|---|---|---|---|---|---|---|---|
| TEAM | Walking | ||||||||
| Group characteristics (n = 18) | |||||||||
| Median (IQR) | n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | Median (IQR) | Median (IQR) | |
| 71 (68-76) | Women: 9 (50) | CT: 15 (83) | 0: 7 (39) | 0: 4 (22) | Coliving: 10 (56) | Retired: 15 (83) | 77% (69-89) | 83% (73-100) | |
| Individual characteristics | |||||||||
| Non–small cell lung cancer (n = 7) | |||||||||
| 1 | 69 | Man | CT | 1 | 2 | Alone | Retired | 75% | 83% |
| 2 | 70 | Woman | CT | 1 | 2 | Alone | Retired | 88% | 83% |
| 3 | 72 | Man | CT | 0 | 1 | Alone | Retired | 0% | 0% |
| 4 | 74 | Woman | IT | 1 | 3 | Alone | Retired | 83% | 100% |
| 5 | 74 | Man | CT | 0 | 1 | Coliving | Retired | 75% | 92% |
| 6 | 74 | Man | IT | 1 | 1 | Coliving | Retired | 63% | 67% |
| 7 | 82 | Man | IT | 0 | 0 | Coliving | Retired | 92% | 75% |
| Pancreatic cancer (n = 9) | |||||||||
| 8 | 65 | Woman | CT | 0 | 0 | Alone | Retired | 96% | 100% |
| 9 | 65 | Man | CT | 0 | 1 | Coliving | Working part time | 96% | 83% |
| 10 | 65 | Woman | CT | 0 | 0 | Coliving | Retired | 75% | 100% |
| 11 | 66 | Woman | CT | 2 | 2 | Alone | Retired | 46% | 42% |
| 12 | 70 | Woman | CT | 1 | 6 | Coliving | Retired | 79% | 100% |
| 13 | 70 | Man | CT | 1 | 2 | Coliving | Working part time | 88% | 100% |
| 14 | 80 | Woman | CT | 1 | 1 | Coliving | Retired | 38% | 17% |
| 15 | 83 | Man | CT | 1 | 2 | Alone | Working part time | 71% | 75% |
| 16 | 83 | Woman | CT | 1 | 0 | Coliving | Retired | 71% | 92% |
| Biliary tract cancer (n = 2) | |||||||||
| 17 | 70 | Man | CT | 0 | 2 | Coliving | Retired | 83% | 100% |
| 18 | 72 | Woman | CT | 2 | 2 | Alone | Retired | 96% | 75% |
Abbreviations: ID, identification number; ECOG PS, Eastern Cooperative Oncology Group Performance Status; CCI, Charlson Comorbidity Index; IQR, interquartile range; CT, chemotherapy; IT, immunotherapy.
a Compliance rates for the TEAM (team-based) exercise is calculated as the percentage of appearances during the 12-week program (24 sessions). Compliance rates for the Walking (walking program) is calculated as the percentage of completed weeks during the 12-week program with full 7-day step count.
FigureIdentified factors affecting feasibility. Summary of perceived motivational and facilitating factors, barriers, risks, and gains as identified in the current study focusing on older patients with advanced cancer participating in a multimodal exercise-based trial in the hospital setting. Each factor affected feasibility and should be considered in future programs.